![]() |
Page History
Scrollbar |
---|
Page info | ||||
---|---|---|---|---|
|
Note | ||
---|---|---|
| ||
This page is being replaced by including the corresponding page from the caGrid Roadmap. Comment from Brian Davis: 1) Re-write to be general for PST and SI roadmaps.
2) "Big pharma" is a stakeholder. Is "small pharma" or "biotech" a different stakeholder? Perhaps safest just to call it "pharma" unless you will break it out.
caGrid 2.0 federated, semantically aware service-oriented architecture (sSOA) enables the development of a continuous and accelerated cycle of scientific discovery, diagnostics, pharmaceutical product development and improved clinical care. This supports diverse stakeholders --- from patients to providers, researchers to regulators, administrators to advocates --- and enables effective collaboration in ways never before possible.
...